1-3 of 3
Gerardo Musuraca
Close
Sort by
Journal Articles

A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma

Clinical Trials & Observations
Annalisa Arcari, Lugi Rigacci, Alessandra Tucci, Benedetta Puccini, Sara Veronica Usai, Federica Cavallo, Alberto Fabbri, Monica Balzarotti, Sabrina Pelliccia, Stefano Luminari, Elsa Pennese, Vittorio Ruggero Zilioli, Abdurraouf Mokhtar Mahmoud, Gerardo Musuraca, Dario Marino, Roberto Sartori, Barbara Botto, Guido Gini, Manuela Zanni, Stefan Hohaus, Giuseppe Tarantini, Leonardo Flenghi, Monica Tani, Alice Di Rocco, Michele Merli, Daniele Vallisa, Chiara Pagani, Luca Nassi, Daniela Dessì, Simone Ferrero, Emanuele Cencini, Patrizia Bernuzzi, Caterina Mammi, Luigi Marcheselli, Valentina Tabanelli, Michele Spina, Francesco Merli
Journal: Blood Advances
Blood Adv (2023) 7 (15): 4160–4169.
https://doi.org/10.1182/bloodadvances.2023009839
Published: 2023
Includes: Supplemental data
Journal Articles

Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma

Clinical Trials & Observations
Anas Younes, John M. Burke, Bruce D. Cheson, Catherine S. Diefenbach, Silvia Ferrari, Uwe H. Hahn, Eliza A. Hawkes, Cyrus Khan, Izidore S. Lossos, Gerardo Musuraca, Monica Tani, Umberto Vitolo, Sam Yuen, Aparna Raval, Mahesh Shivhare, Tina G. Nielsen, Gila Sellam, Jeff P. Sharman
Journal: Blood Advances
Blood Adv (2023) 7 (8): 1488–1495.
https://doi.org/10.1182/bloodadvances.2022008344
Published: 2023
Includes: Supplemental data
Journal Articles

Gene expression profile predicts response to the combination of tosedostat and low-dose cytarabine in elderly AML

Clinical Trials & Observations
Giuseppe Visani, Federica Loscocco, Mike Dennis, Eliana Zuffa, Anna Candoni, Alberto Sensi, Barbara Giannini, Gerardo Musuraca, Anna Maria Mianulli, Marino Clavio, Marco Rocchi, Davide Gibellini, Mohsen Navari, Amanda Gilkes, Pier Paolo Piccaluga, Alessandro Isidori
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5040–5049.
https://doi.org/10.1182/bloodadvances.2020002305
Published: 2020
Includes: Supplemental data